00 Wavelength (Å) 1.5418 Resolution (Å)1 20-2.30 (2.42-2.30)    R merge (%) 12.4 (55.5) I/σI 18.8 (2.6) Completeness (%) 99.6 (98.3) Redundancy 8.9 (6.1) Refinement   Resolution (Å) 20-2.30 (2.42-2.30) No. reflections 54135 R work/R free 0.199/0.233 No. atoms      Protein 7274    Ligand/ion 69    Compound 40    Water 468 B-factors      Protein 24.081    Ligand/ion 38.819    Water 29.006    Compound 42.133 R.m.s deviations      Bond lengths (Å) 0.008    Bond angles (°) 1.4

1Numbers in parentheses represent statistics in highest resolution Vactosertib shell In the complex structure, HpFabZ hexamer displayed a classical “”trimer of dimers”" organization similar to the native HpFabZ structure (PDB code 2GLL). Six monomers of the hexamer arranged a ring-like contact topology (A-B-F-E-C-D-A), and every two monomers (A/B, C/D and E/F) formed dimer each other through hydrophobic interactions. Two L-shaped substrate-binding tunnels with the entrance protected by a door residue Tyr100 were located in the interface of a dimer and ~20 Å away from each other. see more Tyr100 adopted two different conformations. The open conformation, in which the side chain of Tyr100 pointed towards Ile64′ (the prime indicated the residue from the other subunit in the dimer), allowed the chains of substrates to enter

the tunnel. While the closed conformation, in which the side chain of Tyr100 flopped ~120° around the

Cα-Cβ bond and pointed towards residue Pro112′, blocked the entrance of the tunnel and stopped the substrate chain from reaching the catalytic site. The catalytic site in the tunnel was formed by two highly conserved residues, His58 and Glu72′ that were located in the middle kink of the tunnel. Emodin inhibited HpFabZ activity by either binding to Tyr100 or embedding into the middle of the tunnel C appropriately with favorable shape of complementary, thus preventing the substrate from accessing the active site. It bound to tunnels B and C of HpFabZ hexamer with two distinct Liothyronine Sodium interaction models, similar to the binding feature of HpFabZ-compound 1 complex (PDB code: 2GLP) [8] (Fig. 3). The two binding models were shown in Fig. 4. In one model (designated hereinafter as model A in Fig. 4A), Emodin bound to the entrance of tunnel B linearly (Tyr100 of the tunnel came from monomer B). Different from the open and close conformations, the phenol ring of door residue Tyr100 flopped ~120° to a third conformation and paralleled the pyrrolidine ring of Pro112′. Ring A of Emodin was then stacked between the phenol ring and pyrrolidine ring forming a sandwich structure, while 3′-methyl of ring A also interacted with residues Arg110 and Ile111 via hydrophobic interactions.

In our study, the presence of intI1 from SGI1 in the absence of the SGI1 left junction was observed in nine Group B genotypes, two Group C genotypes and never in Group A. Moreover, all the Group B genotypes harboring

the bla TEM gene contained the sul1 determinant. Other such atypical strains were encountered during a European study on the molecular sub-typing of Salmonella genomic islands on a large collection of isolates from different countries. This last study highlighted a correlation between spvC positive strains and the presence of bla TEM not observed in the current study [8]. One of the main genotypes, A9, exhibited the four SPI-2 to -5 determinants in the absence of all the other targeted find more genes. A frequent, closely-related A5 genotype also harbored the same SPI pattern in addition to the plasmid-associated spvC determinant. Along with the B6 and C2 genotypes, these two major A5 and A9 genotypes were detected in all sources, particularly human, poultry and swine sources, which suggest that they are widespread throughout selleck various niches. Salmonella plasmid-encoded virulence factors are a selective advantage to some Salmonella variants for colonizing new niches over the course of Salmonella evolution [21]. Our finding also indicates that Typhimurium strains could share common combinations of markers

whatever their source. In contrast, some genotypes were unique to animal sources: A3, A6, B10, B11, B13 and C3 were unique to poultry sources; B4 and C1 were unique to swine sources. No genotypes were assigned exclusively to human strains, but the number of clinical strains tested was fairly low. Although the studied collection of strains was representative of the main animal and food sources, the Salmonella network collects Salmonella isolates on a voluntary basis. There may, therefore, have been some bias in the selected strains, especially for serotype Typhimurium mainly serotyped in other veterinary or food analysis laboratories. Moreover, the number of strains tested from each source was not 3-oxoacyl-(acyl-carrier-protein) reductase evenly distributed. The

high proportion of poultry isolates is due to European regulations in this production sector, leading to many surveillance and sampling programs with monitoring and official controls. Studies suggest that Salmonella plasmid-encoded virulence factors are a selective advantage to some Salmonella variants for colonizing new niches over the course of Salmonella evolution [21]. Conclusion The GeneDisc® macroarray presented in this study made it possible to easily explore variability of the ten relevant gene determinants within Typhimurium very quickly during a on-hour run. Based on the presence or absence of these markers, 34 different marker combinations (genotypes) were observed among the 538 studied isolates, recovered mainly from food, animal or human sources. Three major genotypes were defined, being observed in 75% of the studied strains.

The full-length virus genome was assembled by a series of ligation steps (Figure 5). First, a 2400-bp XbaI-PstI fragment was release from plasmid pSKE3Δ and cloned into plasmid pGEME12 digested with PstI and XbaI, leading to the construct pGEME123. A 3123-bp SpeI-PstI fragment of the pGEME123 was inserted into the pSKE4 plasmid digested with SpeI and PstI, the resulting plasmid pSKE1234. A 5429-bp SpeI-EcoRI fragment was release from plasmid pSKE1234 and ligated into plasmid pSKE5 digested with EcoRI and SpeI, AZD5582 the resulting plasmid named pRDD, which contained genome-length cDNA clone of Asia1/JSp1c8, was sequenced to confirm

sequence fidelity. Overlapping PLK inhibitor PCRs were used to introduce amino acid substitutions (144

D (gat) to G (ggt), 144 D (gat) to S (agt)) into the structural protein VP1 of Asia1/JSp1c8 virus. Individual parts were amplified with primer pairs TR1/TR1′, TR2/TR2′, TR1/TR3′ and TR3/TR2′ (Table 5), and then both overlapping PCR fusion reactions were performed by mixing PCR-amplified fragments with TR1/TR2′ primer pair. The parameters of two PCRs as following: initial denaturation at 94°C for 1 min, 30 cycles of 98°C for 20 s, 68°C for 1 min, and then 72°C for 8 min. The two fused PCR fragments were digested with EcoRI and SacII and cloned into the full-length plasmid pRDD. The mutated full-length cDNA clones named pRGD, and pRSD, respectively, were sequenced through the entire amplified regions to confirm the presence of the expected modifications. Virus rescue

The plasmids pRDD, pRGD and pRSD were linearized with NotI and purified from agarose gels with columns (Qiagen). BSR-T7/5 cells (4-6 × 105 in a six-well plate) were transfected with mixtures containing 2 μg each of three linearized plasmids and 10 μL Lipofectamine 2000 (Invitrogen) according to the manufacturer’s directions. As a negative control, Lipofectamine 2000 was also used to transfect BSR-T7/5 cells. After 6 h of incubation at 37°C, the cells were added to GMEM supplemented with 10% FBS and further incubated for 72 h at 37°C with Tolmetin 5% CO2. The cell culture supernatants were harvested at 72 h post-transfection and were then serially passaged 10 times on BHK-21 cells to increase virus titers. Replication kinetics of rescued FMDVs Growth kinetics of the viruses was determined in BHK-21 cells. Confluent monolayers in 60 mm diameter plates were infected at a multiplicity of infection (MOI) of 10 PFU per cell with Asia1/JSp1c8 virus and the three genetically engineered viruses. After adsorption for 1 h, the monolayers were washed with 0.01 M phosphate-buffered saline (PBS; pH7.4), and maintained in DMEM supplemented with 2% FBS at 37°C with 5% CO2. The virus-infected supernatants were collected at 4, 8, 12, 16 and 24 h after inoculation.

Based on the ELISA data, the calculated K D for the recombinant proteinLsa33 with PLG is 23.53 ± 4.66 nM (Figure 6C). This K D

value is in the same order of magnitude with the ones obtained with several recombinant proteins in our laboratory [21]. Figure 6 Recombinant proteins PD0332991 cost binding to serum components. (A) Human purified PLG, factor H and C4bp (10 μg/ml) were coated onto ELISA plates and allowed to interact with the recombinant proteins Lsa33 and Lsa25 (10 μg/ml). Gelatin and fetuin were used as negative controls for nonspecific binding. The binding was detected by antibodies raised against each recombinant protein (1:750). Bars represent the mean of absorbance at 492 nm ± the standard deviation of three replicates for each protein and are representative of three independent experiments. For statistical analyses, the binding of Lsa33 and Lsa25 was compared to its binding to gelatin by two – tailed t test (*P < 0.05 and **P < 0.005). (B) Similar as described in (A) but the binding of the recombinant proteins was detected by anti - polyhistidine monoclonal antibodies (1:200). Included

LY2109761 chemical structure is a His – tag recombinant protein Lsa63 that does not bind C4bp. (C) Recombinant proteins dose – dependent binding experiments with PLG. The binding was detected by polyclonal antibodies against each protein; each point was performed in triplicate and expressed as the mean absorbance value at 492 nm ± standard error for each point. Gelatin was included as a negative control. The dissociation

constant (KD) is depicted and was calculated based on ELISA data for the recombinant protein that reached equilibrium. (D) Plasmin generation by PLG bound to recombinant proteins was assayed by modified ELISA as immobilized proteins received the following treatment: PLG + uPA + specific plasmin substrate (PLG + uPA + S), or controls lacking one of the three components (PLG + uPA; PLG + S; uPA + S). Lsa63 and BSA were employed as negative controls. Bars represent mean absorbance at 405 nm, as a measure of relative substrate degradation ± the standard deviation of four replicates for Selleck Forskolin each experimental group and are representative of three independent experiments. Statistically significant binding in comparison to the negative control (BSA) are shown: *P < 0.05. (E) Recombinant proteins dose – dependent binding experiments with C4bp. The binding was detected by polyclonal antibodies raised against each protein (1:750); each point was performed in triplicate and expressed as the mean absorbance value at 492 nm ± standard error for each point. Gelatin was included as a negative control.

Science 1997, 278:1928–1931.CrossRef 67. Thielges MC, Fayer MD: Protein dynamics studied with ultrafast two-dimensional infrared vibrational echo spectroscopy. Accounts Chem Res 2012, 45:1866–1874.CrossRef 68. Mouthuy P-O, Coulombier M, Pardoen T, Raskin J-P, Jonas AM: Overcurvature describes the buckling

and folding of rings from curved origami to foldable tents. Nat Commun 2012, 3:1290.CrossRef 69. Rutter JW: Geometry of Curves. Boca Raton: Chapman & Hall; 2000. 70. Landau LD, Lifshitz EM: S3I-201 cell line Theory of Elasticity. 2nd English edn. Oxford: Pergamon Press; 1970. 71. Grosberg AIU, Khokhlov AR: Statistical Physics of Macromolecules. New York: AIP Press; 1994. 72. Yamakawa H: Modern Theory of Polymer Solutions. New York: Harper & Row; 1971. 73. Hagerman PJ: Flexibility of DNA. Annu Rev Biophys Bio 1988, 17:265–286.CrossRef 74. Brinkers SIS3 ic50 S, Dietrich HRC, De Groote FH, Young IT, Rieger B: The persistence length of double stranded DNA determined using dark field tethered particle motion. J Chem Phys 2009, 130:215105.CrossRef 75. Moras G, Pastewka L, Walter M, Schnagl J, Gumbsch P,

Moseler M: Progressive shortening of sp-hybridized carbon chains through oxygen-induced cleavage. J Phys Chem C 2011, 115:24653–24661.CrossRef 76. Semsey S, Virnik K, Adhya S: A gamut of loops: meandering DNA. Trends Biochem Sci 2005, 30:334–341.CrossRef 77. Zhang Y, McEwen AE, Crothers DM, Levene selleck chemicals llc SD: Statistical-mechanical theory of DNA looping. Biophys J 2006, 90:1903–1912.CrossRef 78. Castelli IE, Ferri N, Onida G, Manini N: Carbon sp chains in graphene nanoholes. J Phys-Condens Mat 2012, 24:104019.CrossRef 79. Xu B, Lin JY, Lim SH, Feng YP: Structural and electronic properties of finite carbon chains encapsulated into carbon nanotubes. J Phys Chem

C 2009, 113:21314–21318.CrossRef 80. Zhao XL, Ando Y, Liu Y, Jinno M, Suzuki T: Carbon nanowire made of a long linear carbon chain inserted inside a multiwalled carbon nanotube. Phys Rev Lett 2003, 90:187401.CrossRef Competing interests The author declares no competing interests.”
“Background Much of the recent effort to develop photovoltaics (PV) has focused on third-generation PV. The third-generation PV is defined by cost and power conversion efficiency (PCE) greater than the Shockley-Queisser limit of 32% [1]. It can be reached through device architecture innovations, multiple-carrier generation using impact ionization, and new materials. Colloidal quantum dots (CQDs) have been proposed as useful materials for third-generation PV because of their ability to generate multiple excitons. Also, by changing the physical dimensions of CQDs, band gaps can be tuned from the visible to the infrared region using low-cost solution-processed fabrication. CQD PV has been studied in various ways using the following: Schottky CQD solar cells [2], depleted heterojunction CQD solar cells [3], and CQD-sensitized solar cells [4].

Wehner T, Bauer S, Hamer HM, et al. Six months of post-marketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany. Epilepsy Behav 2009 Nov; 16(3): 423–5PubMedCrossRef 18. Parkerson KA, Reinsberger Wee1 inhibitor C, Chou SH, et al. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill

patients. Epilepsy Behav 2011 Jan; 20(1): 48–51PubMedCrossRef 19. Sake JK, Hebert D, Isojarvi J, et al. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. CNS Drugs 2010 Dec 1; 24(12): 1055–68PubMedCrossRef”
“Introduction Antihistamines were first introduced in the 1940s and represent one of the most commonly used medications today.[1] The first-generation antihistamine doxylamine

succinate is a member of the ethanolamine class and was introduced into clinical use in the EU in the late 1950s. It acts by competitively inhibiting histamine at H1 receptors, the binding being readily reversible. It has hypnotic, anticholinergic, and local anesthetic effects, and shares the actions and uses of other antihistamines. The effects upon the central nervous system are fundamentally determined by the capacity to cross the blood–brain barrier and bind to the central H1 receptors.[2–4] Although sedation sometimes limits the clinical usefulness of doxylamine when GDC-0068 concentration ID-8 that effect is not desirable, it also provides an additional indication, shared by other antihistamines in the ethanolamine group: symptomatic treatment of insomnia.[1–3,5,6] Currently, doxylamine medicinal products have been authorized for more than 50 years, with an appropriate extent of use, for symptomatic treatment of occasional insomnia, making doxylamine a drug with a well established use. In fact, doxylamine alone or in combination with other drugs is available over the

counter in Australia, Belgium, Canada, France, Germany, Hungary, Ireland, Italy, Korea, New Zealand, Poland, Portugal, Slovenia, Spain, Switzerland, the UK, and the US. Dormidina® has been marketed in Spain since 1990 with a unique active ingredient: doxylamine hydrogen succinate 25 mg or 12.5 mg. Doxylamine hydrogen succinate 25 mg (salt) corresponds to doxylamine 17.4 mg (base). Doxylamine is indicated for the symptomatic treatment of occasional insomnia in adults aged 18 years and over, particularly those with difficulty in falling asleep, frequent interruptions during sleep, or early waking in the morning. Because its marketing authorization was approved before the implementation of the present regulatory standards, pharmacokinetic studies of doxylamine hydrogen succinate in its current pharmaceutical presentation (film-coated tablets) have never been performed under fed conditions.

and Phaseolus vulgaris (L). Acta Microbiologica Polonica 1985, 34:187–196.PubMed 19. Ramírez ME, Israel DW, Wollum AG II: Using spontaneous antibiotic-resistant mutants to assess competitiveness of bradyrhizobial inoculants

for nodulation of soybean. Canadian Journal of Microbiology 1998, 44:753–758.CrossRef 20. Zelazna-Kowalska I: Correlation between streptomycin resistance and infectiveness in Rhizobium trifolii. Plant and Soil 1971, special:67–71.CrossRef 21. Turco RF, Moorman TB, Bezdicek DF: Effectiveness and competitiveness of spontaneous antibiotic-resistant mutants of Rhizobium leguminosarum and Rhizobium japonicum. Soil Biology and Biochemistry 1986, 18:259–262.CrossRef 22. Lochner HH, Strijdom BW, Law IJ: Unaltered nodulation competitiveness of a strain of Bradyrhizobium sp. (Lotus) after a decade in soil. Applied and Environmental Microbiology 1989, 55:3000–3008.PubMed 23. Lochner

HH, Strijdom BW, Steyn PL: Limitations CP673451 ic50 of colony morphology and antibiotic resistance in the identification of a Bradyrhizobium sp. (Lotus) in soil. Biology and Fertility of Soils 1991, 11:128–134.CrossRef 24. Brockwell J, Schwinghamer EA, Gault RR: Ecological studies of root-nodule bacteria introduced check details into field environments V: A critical examination of the stability of antigenic and streptomycin-reistant markers for identification of strains of Rhizobium trifolii. Soil Biology and Biochemistry 1977, 9:19–24.CrossRef 25. Diatloff A: Ecological studies of root-nodule bacteria introduced into field environments

6: Antigenic and symbiotic stability in Lotononis rhizobia over Temsirolimus mouse a 12-year period. Soil Biology and Biochemistry 1977, 9:85–88.CrossRef 26. Berger JA, May SN, Berger LR, Bohlool BB: Colorometric enzyme-limked immunosorbent assay for the idenitification of strains of Rhizobium in culture and in the nodules of lentils. Applied and Environmental Microbiology 1979, 37:642–646.PubMed 27. Bohlool BB, Schmidt EL: Immunofluorescent detection of Rhizobium japonicum in soils. Soil Science 1970, 10:229–236.CrossRef 28. Kosslak RM, Bohlool BB, Dowdle S, Sadowsky MJ: Competition of Rhizobium japonicum strains in early stages of soybean nodulation. Applied and Environmental Microbiology 1983, 46:870–873.PubMed 29. Josephson KL, Bourque DP, Bliss FA, Pepper IL: Competitiveness of Kim 5 and Viking 1 bean rhizobia: Strain by cultivar interactions. Soil Biology and Biochemistry 1991, 23:249–253.CrossRef 30. Fuhrmann J, Wollum AG II: Simplified Enzyme-linked Immunosorbent Assay for Routine Identification of Rhizobium Japonicum Antigens. Applied and Environmental Microbiology 1985, 49:1010–1013.PubMed 31. Martensson AM, Gustafsson JG, Ljunggren HD: A modified, highly sensitive enzyme-linked immunosorbent assay (ELISA) for Rhizobium meliloti strain identification. Journal of General Microbiology 1984, 130:247–253. 32.

Therefore, the purpose of this study is to verify the effects of Cr supplementation and intense resistance training on muscle strength and GSK2118436 molecular weight oxidative stress of athletes. Methods Subjects Twenty-six male handball athletes (17.10 ± 1.63 years; ranging from 15 to 19 years old) from Sorocaba, SP, Brazil participated in this experiment. Exclusion criteria were: i) no previous experience in resistance training, ii) current use of any nutritional supplement, iii) current or previous intake of anabolic androgenic steroids, iv) current or previous intake of Cr and maltodextrin for supplemental purposes,

and v) pre-existing abnormalities revealed in laboratory tests or medical exam at the beginning of experimental analysis. All experimental procedures were

performed ACP-196 mouse in accordance with the Helsinki Declaration and the guidelines established by the Brazilian National Committee of Research on Human Subjects. The Catholic University Human Subjects Ethics Committee approved all experimental procedures. All subjects provided written consent prior to participating in this study according to the Brazilian Ministry of Health/National Health Foundation. Experimental procedures A randomized, double-blind, placebo-controlled study with subjects divided into 3 groups: GC (N = 9) Cr monohydrate supplemented, GP (N = 9), a placebo group that consumed maltodextrin [16], and COT (N = 8), a group of athletes who did not receive Cr or placebo. All individuals (GC, GP, and COT) underwent a 32-day resistance selleck kinase inhibitor training program that began and finished concomitantly with Cr and Placebo supplementation. One day prior to Cr/Placebo supplementation and resistance training, and one day

following completion of Cr/Placebo supplementation and resistance training, a blood sample from the cubital vein was drawn for verification of oxidative stress parameters, body composition was assessed, and muscle strength and endurance tests were applied to all athletes. All athletes were examined by a sports medicine doctor before, during, and after completion of study. No abnormalities were found in subjects’ health condition at any time during the survey. The protocol used for clinical examination was carried out in accordance with the recommendations from the International Olympic Committee. Moreover, subjects were asked weekly about the occurrence of the following symptoms: increased thirst, fatigue, frequent headaches, frequent irritability, tinnitus, numbness in the head, neck, back, or limbs, shivering and chills, nausea, diarrhea, stomach discomfort, cramps, and dizziness. All athletes had frequent consultations with the team’s physician about the occurrence of muscle or joint injuries or other clinical conditions.

2013 for recent reviews). Research on all aspects of biocrust biology and their influence on ecosystems, traditionally performed by researchers in a few countries, such as the USA, Australia, Israel, and Germany has become a truly global research endeavor, with the emergence of many groups in countries such as China, Spain, and Mexico (Castillo-Monroy and Maestre 2011). The biocrust research community is more interconnected than ever before, as evidenced by GSK2399872A price the multiple collaborations

that are being established among the different groups, by the ongoing preparation of a new book on the status of the field featuring authors from all the continents (Weber et al. 2014), and by the recent establishment of an international series of conferences focusing on biocrusts. The second of these conferences, “Second International Workshop on Biological Soil Cruts: Biological Soil Crusts in a Changing World (Biocrust 2013)” took place in Madrid on 10–13 https://www.selleckchem.com/products/pexidartinib-plx3397.html June 2013. This meeting brought together over 100 researchers from all the continents, who shared during 3 days the results of the most recent research on this ecosystem, and had the opportunity to discuss the status of basic and applied research on biocrusts, and further to start new research initiatives and collaborations to further develop this field further. This special issue includes 13 reviews and primary research articles that derive from communications presented

at the Biocrust 2013 conference, and that reflect the wide variety of topics that biocrust researchers are studying worldwide. The amount of information on biocrusts and their effects on ecosystems currently available has recently fostered their use to test ecological theories, particularly at community Fludarabine and ecosystem levels (see Bowker et al. 2010a; Maestre et al. 2012 for examples). In the first article of this issue, Bowker et al. (2014) review how biocrusts can be used as a model system in community, landscape, and ecosystem ecology. These authors discuss the main features of biocrusts that make them such a useful model system to study multiple

topics in these disciplines, and exemplify how the use of biocrusts in this way can provide novel insights and refine existing theory. Büdel et al. (2014) present the European research initiative ‘‘Soil Crust International’’ (SCIN; http://​www.​soil-crust-international.​org/​), a project focusing on the biodiversity of biocrusts and on functional aspects in their specific environments in four sites located along a wide European gradient (Tabernas, Spain; Hochtor-Großglockner, Austria; Gynge Alvar, Sweden; and Homburg, Germany). In this article, the authors present some preliminary results from the project, which already point out the importance of protecting biocrusts and the development of appropriate ways to manage the biodiversity of these communities along the latitudinal and altitudinal gradient studied.

1% CAA was added to this media, along with NH4Cl, as nitrogen source. Spot inoculation of V. paradoxus EPS, P. aeruginosa PAO1, and Escherichia coli S17-1 on this swarming agar was performed (Fig 1). V. paradoxus EPS and P. aeruginosa PAO1 show strong swarming activity on this media, although the patterns are strikingly different. E. coli S17-1 shows no swarming, but robust growth, on this medium. Using gradient plates, we determined that glucose was not a suitable substrate

for swarming on FW based media using NH4Cl as nitrogen source (not shown). Figure 1 Variovorax paradoxus displays swarming motility. AZD5153 concentration Swarming plates with glucose and casamino acids inoculated with drops of P. aeruginosa PAO-1 (A), V. paradoxus EPS (B), or E. coli S17-1 (C). Inhibition of Swarming

with Congo Red Swarming requires the presence of flagellar activity, which is inhibited by Congo Red (CR) [40]. Supplementing plates with ≥ 50 μg/L CR had a strong inhibitory effect on the swarming phenotype (Fig 2). The colony did expand in diameter over a 48 h period under CR conditions, but at a much lower rate, consistent with simple growth based expansion. The microscopic analysis of the colony edges (Fig 3E–H) shows that the morphology of the edge differs markedly on plates containing CR. Robust growth of V. paradoxus EPS was observed under all CR Rabusertib treatment conditions (Fig 3A–D). Figure 2 Swarming of V. paradoxus EPS is inhibited in a dose dependent manner by the presence of Congo Red in the agar. Plates containing doses of Congo Red ranging from 1–1000 μg/L were incubated at 30°C either A) under ambient atmospheric humidity or B) in a humidified glass dish. Symbols in both panels:

No CR (black diamond), 1 μg/L CR (open square), 10 μg/L CR (filled triangle), 50 μg/L CR (×), 100 μg/L(*), 500 μg/L CR (open circle), 1000 μg/L (+). Swarm diameter measured in triplicate, reported as mean ± SEM. Figure 3 Humidity affects response to Congo Red swarming inhibition. A-D) gross morphology of V. paradoxus EPS on plates incubated at 30°C on media containing 0, 10,100, and 500 μg/L CR after 48 h. E-H) Edge images from the same culture conditions at 24 h. I-L) gross morphology of 48 h cultures on identical media incubated at 30°C in a humidified chamber. M-P) edge images from the humidified chamber incubated cultures at 24 h. Scale bar = 25 Orotidine 5′-phosphate decarboxylase microns. Role of a wetting agent in swarming Swarming is dependent on the presence of a wetting agent, which can be seen spreading on the plate (Fig 4A, B). Wetting agent is observed spreading well in advance of the colony on media containing inhibitory levels of CR (Fig 4B). The wetting agent is evident on plates without CR during the first 2d of growth (Fig 4A), and the wetting agent reduces the surface tension of the agar plate, as shown using a qualitative water drop collapse assay (Fig 4C). Figure 4 A wetting agent is present beyond the edge of the swarm.